During the past decade, Guthrie Cancer Center at Guthrie Clinic Sayre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 22 clinical trials were completed, i.e. on average, 1100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Guthrie Cancer Center at Guthrie Clinic Sayre" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 9 trials, followed by "SWOG Cancer Research Network" with 5 trials sponsored, "Radiation Therapy Oncology Group" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "Eastern Cooperative Oncology Group" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Guthrie Cancer Center at Guthrie Clinic Sayre" #1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Guthrie Cancer Center at Guthrie Clinic Sayre" are "Breast Cancer" (9 trials), "Lung Cancer" (3 trials), "Prostate Cancer" (3 trials), "Colorectal Cancer" (2 trials) and "Head and Neck Cancer" (2 trials). Many other conditions were trialed in "Guthrie Cancer Center at Guthrie Clinic Sayre" in a lesser frequency.

Most popular intervention types in "Guthrie Cancer Center at Guthrie Clinic Sayre" are "Drug" (24 trials), "Biological" (10 trials), "Other" (6 trials), "Radiation" (6 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (4 trials), "radiation therapy" (4 trials), "bevacizumab" (3 trials), "cetuximab" (3 trials) and "docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Guthrie Cancer Center at Guthrie Clinic Sayre" are 20 trials for "All" genders, 6 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Guthrie Cancer Center at Guthrie Clinic Sayre". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Guthrie Cancer Center at Guthrie Clinic Sayre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Guthrie Cancer Center at Guthrie Clinic Sayre, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".